Trailing Twelve Months Revenue Growth: Nuvectis Pharma, Inc (NVCT)

Public company logo of nuvectis.com (NVCT)

Nuvectis Pharma, Inc. (NVCT) protects its positions with kinase inhibitor patents under strict FDA oversight. The development of unique molecules for resistant tumors minimizes direct competition. Annual revenue growth on a TTM basis visualizes these processes, where 0.00 determines the current value of the metric. However, competing with pharma behemoths and the risk of clinical delays make investments in the sector extremely hazardous.

Nuvectis Pharma, Inc. (NVCT): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Nuvectis Pharma, Inc. - analytical breakdowns and key metrics (NVCT)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Nuvectis
Brand item of Nuvectis Pharma, Inc

This indicator captures the percentage change in aggregate revenue over a rolling twelve-month period, allowing investors to assess business scaling dynamics without quarterly lags. An analysis of relative revenue growth over the last four quarters compared to the previous year demonstrates the monetization efficiency of Nuvectis Pharma, Inc. (NVCT) digital bio-screening and AI algorithms, which automate the search for oncology drugs by replacing manual labor with robotic systems.

Who Nuvectis Pharma, Inc. competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Nuvation Bio Inc.|DAWN: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Monopar Pharma MNPR|Revenue Growth YoY (Last 12 Months) INBX|Trailing Twelve Months Revenue Growth I-Mab Biopharma IMAB|Revenue Growth YoY (Last 12 Months) FENC (Fennec Pharmaceuticals)|HRTX (Heron Therapeutics Inc) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)